NCT07426952

Brief Summary

This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer two main questions:

  • Can study team successfully recruit and keep participants in the study, and will the participants find the program helpful and easy to follow?
  • Will participants who join the program see better results in areas like weight, symptoms, diet, physical activity, and confidence in managing the participant's health compared to those who receive standard care? Here's what participants will do:
  • Visit the participant's clinic twice (about 12 weeks apart) to be weighed, have the blood pressure checked, give a blood sample, and complete a short walking test
  • Fill out online surveys about the participant's health, diet, physical activity, symptoms, and confidence in managing the participant's health
  • Be randomly assigned (like flipping a coin) to either receive the WeCan-Rural program or standard health information
  • If assigned to the program, attend 12 weekly one-hour video sessions on Zoom with a trained therapist

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jan 2026

Geographic Reach
1 country

3 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jan 2026Dec 2026

Study Start

First participant enrolled

January 13, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 19, 2026

Status Verified

February 1, 2026

Enrollment Period

12 months

First QC Date

February 17, 2026

Last Update Submit

May 15, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Satisfaction with Treatment and Interventionist as measured by the Satisfaction with Therapy and Therapist Scale-Revised (STTS-R)

    Participants will complete the 13-item Satisfaction with Therapy and Therapist Scale-Revised specific to the program they received. The first 12 items ask participants to rate their agreement with statements related to intervention satisfaction on a 5-point scale ranging from "strongly disagree" (1) to "strongly agree" (5). The 13th item asks "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" to "made things a lot worse."

    Post-treatment (about 12-14 weeks after baseline)

  • Acceptability as measured by the Treatment Acceptability Questionnaire

    The Treatment Acceptability Questionnaire is a six-item scale assessing participants' views of an intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable") and averaged.

    Post-treatment (about 12-14 weeks after baseline)

Secondary Outcomes (19)

  • Change in blood pressure (systolic and diastolic)

    From Baseline to Post-treatment (about 12-14 weeks after baseline)

  • Change in weight

    From Baseline to Post-treatment (about 12-14 weeks after baseline)

  • Change in total cholesterol

    From Baseline to Post-treatment (about 12-14 weeks after baseline)

  • Change in LDL cholesterol

    From Baseline to Post-treatment (about 12-14 weeks after baseline)

  • Change in HDL cholesterol

    From Baseline to Post-treatment (about 12-14 weeks after baseline)

  • +14 more secondary outcomes

Other Outcomes (3)

  • Food environment as measured by the Perceived Nutrition Environment Measure

    Baseline

  • Assessment of rurality as measured by selected items from the Rural Active Living Perceived Support Scale

    Baseline

  • Health literacy as measured by Medical Term Recognition Test (METER)

    Baseline

Study Arms (2)

WeCan-Rural

EXPERIMENTAL

Participants will receive the WeCan-Rural intervention, which includes twelve sessions delivered remotely (i.e., videoconferencing) by a trained therapist.

Behavioral: WeCan-Rural Program

Control

NO INTERVENTION

Participants will receive the National Cancer Institute-developed booklet "Facing Forward: Life After Cancer Treatment," which presents information about cancer survivorship topics.

Interventions

The WeCan-Rural program includes 12, one-hour weekly sessions via Zoom that help breast cancer survivors manage symptoms like pain, fatigue, and emotional distress, while also building healthy habits around eating, exercise, and weight management.

WeCan-Rural

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years or older
  • female (biological sex)
  • diagnosis of stage I-III breast cancer
  • completed treatments with curative intent (with the exception of hormonal treatments) in the last 5 years
  • body mass index \>30
  • healthy enough to participate in home-based physical activity
  • able to speak/read English
  • reports rating of ≥4 (i.e., moderate or more severe) out of 10 for one or more of the following symptoms at its worst in the last month (per the MD Anderson Symptom Inventory): pain, fatigue, sadness, and/or distress

You may not qualify if:

  • visual, hearing or cognitive impairment or severe mental illness interfering with participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Maria Parham Cancer Center

Henderson, North Carolina, 27536, United States

Location

Scotland Health

Laurinburg, North Carolina, 28352, United States

Location

UNC Health Southeastern

Lumberton, North Carolina, 28358, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Caroline Dorfman, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2026

First Posted

February 23, 2026

Study Start

January 13, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations